INTERFERON-ALPHA-2-INDUCED STIMULATION OF ACTH AND CORTISOL SECRETION IN MAN

被引:39
作者
MULLER, H [1 ]
HAMMES, E [1 ]
HIEMKE, C [1 ]
HESS, G [1 ]
机构
[1] UNIV MAINZ, INTERNAL MED 1 CLIN, W-6500 MAINZ, GERMANY
关键词
INTERFERON-ALPHA-2; ACTH; CORTISOL; HEPATITIS-B; NEUROIMMUNE INTERACTIONS;
D O I
10.1159/000125944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Short-term effects of interferon-alpha-2 on plasma concentrations of adrenocorticotrophic hormone (ACTH) and cortisol were measured in man in relation to interferon absorption. Interferon-alpha-2 Was given subcutaneously at a dose of 3 x 10(06) IU at 17.00 h to 2 female and 5 male patients who suffered from chronic hepatitis B infection and who had not previously been treated with interferon. Plasma levels of ACTH, cortisol and interferon-alpha were determined at 30-min intervals between 16.00 and 24.00 h. In each patient a similar cortisol, ACTH and interferon-alpha profile was determined on a day, when no interferon-alpha treatment was given. Interferon-alpha plasma levels peaked around 21.30 h, i.e. 4.7 h after injection. In each patient ACTH and cortisol levels were increased. As calculated from the areas under the curves, ACTH release was increased by an average of 332% (maxima at about 22.00 h, i.e. 5.2 h post injection); cortisol release was increased by an average of 31 1% (maxima at about 23.00 h, 5.8 h post injection). These actions were not related to side effects like fever or other flu-like symptoms. Our findings confirm that in man as in animals interferon-alpha-2 can act as a mediator between the immune and endocrine system.
引用
收藏
页码:499 / 503
页数:5
相关论文
共 27 条
[1]  
BERMAN E, 1990, BLOOD, V75, P839
[2]   HUMAN-LEUKOCYTE INTERFERON - STRUCTURAL AND BIOLOGICAL RELATEDNESS TO ADRENOCORTICOTROPIC HORMONE AND ENDORPHINS [J].
BLALOCK, JE ;
SMITH, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10) :5972-5974
[3]   A CRITICAL-ASSESSMENT OF THE INTERACTIONS BETWEEN THE IMMUNE-SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS [J].
BUZZETTI, R ;
MCLOUGHLIN, L ;
SCAVO, D ;
REES, LH .
JOURNAL OF ENDOCRINOLOGY, 1989, 120 (02) :183-187
[4]   RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
MARTIN, P ;
KASSIANIDES, C ;
LISKERMELMAN, M ;
MURRAY, L ;
WAGGONER, J ;
GOODMAN, Z ;
BANKS, SM ;
HOOFNAGLE, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1506-1510
[5]   TOXICITY OF INTERFERON AND INTERLEUKIN [J].
FENT, K ;
ZBINDEN, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (03) :100-105
[6]   QUANTITATIVE-DETERMINATION OF LYMPHOCYTE ACTH1-39 [J].
FERREIRA, JA ;
CARSTENS, ME ;
TALJAARD, JJF .
NEUROPEPTIDES, 1990, 15 (01) :11-15
[7]  
GALLATI H, 1982, J CLIN CHEM CLIN BIO, V20, P907
[8]   INTERFERON THERAPY FOR KAPOSI SARCOMA ASSOCIATED WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) [J].
GROOPMAN, JE ;
SCADDEN, DT .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) :335-337
[9]  
Hall N., 1984, IMMUNE MODULATION AG, P533
[10]   ACUTE ADRENOCORTICAL STIMULATION BY RECOMBINANT GAMMA-INTERFERON IN HUMAN CONTROLS [J].
HOLSBOER, F ;
STALLA, GK ;
VONBARDELEBEN, U ;
HAMMANN, K ;
MULLER, H ;
MULLER, OA .
LIFE SCIENCES, 1988, 42 (01) :1-5